---
title: "SHANGHAI KAIBAO: The Shanghai Securities Regulatory Bureau has ordered the company to make corrections and issued warning letters to relevant personnel"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289187770.md"
description: "SHANGHAI KAIBAO announced that it received a corrective measure order from the Shanghai Securities Regulatory Bureau and a warning letter issued to four executives including Mu Jingwei. The company has issues such as using employees' personal bank cards for secondary salary distribution, irregularities in collecting social security payments and labor fees, and discrepancies in accounting for sales expenses. Relevant responsible persons have been held accountable"
datetime: "2026-06-09T12:15:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289187770.md)
  - [en](https://longbridge.com/en/news/289187770.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289187770.md)
---

# SHANGHAI KAIBAO: The Shanghai Securities Regulatory Bureau has ordered the company to make corrections and issued warning letters to relevant personnel

According to the announcement from Shanghai Kaibao (300039.SZ), the company has received a decision from the Shanghai Securities Regulatory Bureau of the China Securities Regulatory Commission (referred to as "Shanghai Securities Regulatory Bureau") regarding the implementation of corrective measures against Shanghai Kaibao Pharmaceutical Co., Ltd. and the issuance of warning letters to Mu Jingwei, Zhou Yingbin, Ren Liwang, and Chen Youlong.

It is reported that the company has issues such as using employees' personal bank cards for secondary salary distribution, using employees' personal bank cards to collect social security payments, irregularities in labor fee disbursement, and discrepancies between sales expense accounting and actual expenses incurred. Mu Jingwei, as the chairman of the company, Zhou Yingbin, as a director and general manager, Ren Liwang, as a director and then financial director and board secretary, and Chen Youlong, as the current financial director, are responsible for the company's aforementioned violations

### Related Stocks

- [300039.CN](https://longbridge.com/en/quote/300039.CN.md)

## Related News & Research

- [A SpaceX 'investment coma' is driving this major space ETF toward its worst month in 6 years](https://longbridge.com/en/news/290733525.md)
- [PRES TRUMP CANCELS SIGNING OF FRESHLY PASSED HOUSING BILL, ADDING IT TO HIS HOSTAGE CAMPAIGN TO GET 'SAVE AMERICA' VOTING RIGHTS BILL PASSED FIRST](https://longbridge.com/en/news/290712240.md)
- [Nemetschek online talk survey shows AI use rises across architecture, planning firms](https://longbridge.com/en/news/290843482.md)
- [Insider Share Purchases Boost Stake in Jinhui Shipping](https://longbridge.com/en/news/290659029.md)
- [16:19 ETGlobal Seafood Alliance Releases its 2025 Annual Report](https://longbridge.com/en/news/290875893.md)